Mark Pegram
Associate Dean for Clinical Research Quality, Stanford School of Medicine · Stanford Health Care
Credentials: · ·
History
- Present
Stanford School of Medicine · Stanford Health Care
- Present
Translational Oncology Research Program @ Stanford (TOP@S) · Stanford Health Care
- Present
Stanford School of Medicine · Stanford Health Care
1990–1993
Research
New England Journal of Medicine · 2001 · 8,905 citations
Trastuzumab emtansine for HER2-positive advanced breast cancer
New England Journal of Medicine · 2012 · 2,970 citations
Journal of Clinical Oncology · 2007 · 2,893 citations
38 papers
14 papers
11 papers
10 papers
8 papers
- IK
8 papers
- MP
8 papers
7 papers
Grants
- 2007–2022
National Cancer Institute · P30
Project lead · $220.4K · Stanford University
- 2009–2015
A Neoadjuvant Trial of Anastrazole and A Novel SRC Inhibitor, AZD0530, for LABC
National Cancer Institute · R21
PI · $592K · University of Miami School of Medicine
- 2009–2012
Molecular Analysis of NeoAdjuvant Platinum in Triple Negative Breast Cancer
National Cancer Institute · RC1
Contact PI · $996.1K · University of Miami School of Medicine
Clinical trials
- 2013–2015
Recombinant Human Hyaluronidase in Treating Lymphedema in Patients With Cancer
Principal investigator · Terminated · Phase 1, Phase 2
Stanford University
- 2008–2009
Principal investigator · Terminated · Phase 2
Stanford University
- 2005–2007
PR-104 in Treating Patients With Advanced Solid Tumors
Principal investigator · Completed · Phase 1
Proacta, Incorporated
- 2004–2005
Principal investigator · Completed · Phase 2
Jonsson Comprehensive Cancer Center